Recovery of Cranial Nerve Neuropathies After LINAC-based Stereotactic Radiosurgery for Benign Cavernous Sinus Meningioma

Overview

Journal J Neurooncol

Publisher Springer

Date 2024 Aug 1

PMID 39088156

Authors

Tehila Kaisman-Elbaz

Philip Blumenfeld

Marc Wygoda

John Feldman

Yigal Shoshan

Affiliations

Soon will be listed here.

Abstract

Purpose: Cranial Nerve Neuropathies (CNNs) often accompany Cavernous Sinus Meningioma (CSM), for which Stereotactic Radiosurgery (SRS) or fractionated stereotactic radiotherapy (FSR) are established treatments. This study assesses CNNs recovery in CSM patients treated with LINAC, offering insight into treatment effectiveness.

Methods: This study was conducted on 128 patients with CSM treated with LINAC-based SRS/FSR between 2005 and 2020 at a single institution. 46 patients presented with CNNs. The study analyzed patients' demographics, clinical parameters, SRS/FSR treatment characteristics, post-treatment CNNs recovery duration, status, and radiological control on their last follow-up.

Results: The median follow-up duration was 53.4 months. Patients were treated with SRS (n = 25) or FSR (n = 21). The mean pretreatment tumor volume was 9.5 cc decreasing to a mean end-of-follow-up tumor volume was 5.1 cc. Radiological tumor control was achieved in all cases. CNN recovery was observed in 80.4% of patients, with specific nerve recoveries documented as follows: extra-ocular nerves (43.2%), trigeminal nerve (32.4%), and optic nerve (10.8%). A higher CNNs recovery rate was associated with a smaller pre-treatment tumor volume (p < 0.001), and the median time-to-improvement was 3.7 months. Patients with tumor volumes exceeding 6.8 cc and those treated with FSR exhibited prolonged time-to-improvement (P < 0.03 and P < 0.04 respectively).

Conclusions: This study suggests that SRS/FSR for CSM provides good and sustainable CNNs recovery outcomes with excellent long-term radiological control. A higher CNNs recovery rate was associated with a smaller pre-treatment tumor volume. while shorter time-to-improvement was identified in patients treated with SRS compared to FSR, particularly in those with small pre-treatment tumor volume.

References

Kano H, Park K, Kondziolka D, Iyer A, Liu X, Tonetti D . Does prior microsurgery improve or worsen the outcomes of stereotactic radiosurgery for cavernous sinus meningiomas?. Neurosurgery. 2013; 73(3):401-10. DOI: 10.1227/01.neu.0000431471.64289.3d. View

Chung L, Mathur I, Lagman C, Bui T, Lee S, Voth B . Stereotactic radiosurgery versus fractionated stereotactic radiotherapy in benign meningioma. J Clin Neurosci. 2016; 36:1-5. DOI: 10.1016/j.jocn.2016.10.009. View

Corniola M, Roche P, Bruneau M, Cavallo L, Daniel R, Messerer M . Management of cavernous sinus meningiomas: Consensus statement on behalf of the EANS skull base section. Brain Spine. 2022; 2:100864. PMC: 9560706. DOI: 10.1016/j.bas.2022.100864. View

Hafez R, Morgan M, Fahmy O . Stereotactic Gamma Knife surgery safety and efficacy in the management of symptomatic benign confined cavernous sinus meningioma. Acta Neurochir (Wien). 2015; 157(9):1559-64. DOI: 10.1007/s00701-015-2509-2. View

Hasegawa T, Kida Y, Yoshimoto M, Koike J, Iizuka H, Ishii D . Long-term outcomes of Gamma Knife surgery for cavernous sinus meningioma. J Neurosurg. 2007; 107(4):745-51. DOI: 10.3171/JNS-07/10/0745. View

Hung Y, Lee C, Guo W, Shiau C, Chang Y, Pan D . Gamma knife radiosurgery for the treatment of cavernous sinus meningiomas: post-treatment long-term clinical outcomes, complications, and volume changes. J Neurooncol. 2019; 143(2):261-270. DOI: 10.1007/s11060-019-03090-6. View

Spiegelmann R, Cohen Z, Nissim O, Alezra D, Pfeffer R . Cavernous sinus meningiomas: a large LINAC radiosurgery series. J Neurooncol. 2010; 98(2):195-202. DOI: 10.1007/s11060-010-0173-1. View

Metellus P, Batra S, Karkar S, Kapoor S, Weiss S, Kleinberg L . Fractionated conformal radiotherapy in the management of cavernous sinus meningiomas: long-term functional outcome and tumor control at a single institution. Int J Radiat Oncol Biol Phys. 2010; 78(3):836-43. DOI: 10.1016/j.ijrobp.2009.08.006. View

Correa S, Marta G, Teixeira M . Neurosymptomatic carvenous sinus meningioma: a 15-years experience with fractionated stereotactic radiotherapy and radiosurgery. Radiat Oncol. 2014; 9:27. PMC: 3904186. DOI: 10.1186/1748-717X-9-27. View

10.

Shimol E, Joskowicz L, Eliahou R, Shoshan Y . Computer-based radiological longitudinal evaluation of meningiomas following stereotactic radiosurgery. Int J Comput Assist Radiol Surg. 2017; 13(2):215-228. DOI: 10.1007/s11548-017-1673-7. View

11.

Dos Santos M, Perez de Salcedo J, Gutierrez Diaz J, Calvo F, Samblas J, Marsiglia H . Long-term outcomes of stereotactic radiosurgery for treatment of cavernous sinus meningiomas. Int J Radiat Oncol Biol Phys. 2010; 81(5):1436-41. DOI: 10.1016/j.ijrobp.2010.07.2002. View

12.

Leroy H, Tuleasca C, Reyns N, Levivier M . Radiosurgery and fractionated radiotherapy for cavernous sinus meningioma: a systematic review and meta-analysis. Acta Neurochir (Wien). 2018; 160(12):2367-2378. DOI: 10.1007/s00701-018-3711-9. View

13.

Faramand A, Kano H, Niranjan A, Johnson S, Hassib M, Park K . Cranial nerve outcomes after primary stereotactic radiosurgery for symptomatic skull base meningiomas. J Neurooncol. 2018; 139(2):341-348. DOI: 10.1007/s11060-018-2866-9. View

14.

Nunes F, Merker V, Jennings D, Caruso P, Tomaso E, Muzikansky A . Bevacizumab treatment for meningiomas in NF2: a retrospective analysis of 15 patients. PLoS One. 2013; 8(3):e59941. PMC: 3605344. DOI: 10.1371/journal.pone.0059941. View

15.

Feigl G, Samii M, Horstmann G . Volumetric follow-up of meningiomas: a quantitative method to evaluate treatment outcome of gamma knife radiosurgery. Neurosurgery. 2007; 61(2):281-6. DOI: 10.1227/01.NEU.0000279999.95953.EA. View

16.

Umekawa M, Shinya Y, Hasegawa H, Shin M, Kawashima M, Katano A . Long-term outcomes of stereotactic radiosurgery for skull base tumors involving the cavernous sinus. J Neurooncol. 2022; 156(2):377-386. DOI: 10.1007/s11060-021-03921-5. View

17.

Sughrue M, Rutkowski M, Aranda D, Barani I, McDermott M, Parsa A . Factors affecting outcome following treatment of patients with cavernous sinus meningiomas. J Neurosurg. 2010; 113(5):1087-92. DOI: 10.3171/2010.3.JNS091807. View

18.

Shoshan Y, Wygoda M, Umansky F . Stereotactic radiosurgery and fractionated stereotactic radiotherapy: background, definitions, applications. Isr Med Assoc J. 2005; 7(9):597-9. View

19.

Martinez-Perez R, Florez-Perdomo W, Freeman L, Ung T, Youssef A . Long-term disease control and treatment outcomes of stereotactic radiosurgery in cavernous sinus meningiomas. J Neurooncol. 2021; 152(3):439-449. DOI: 10.1007/s11060-021-03732-8. View

20.

Amelot A, van Effenterre R, Kalamarides M, Cornu P, Boch A . Natural history of cavernous sinus meningiomas. J Neurosurg. 2018; 130(2):435-442. DOI: 10.3171/2017.7.JNS17662. View